Cutter & CO Brokerage, Inc. Vertex Pharmaceuticals Inc Transaction History

Cutter & CO Brokerage, Inc.

$376 Million
Q4 2024

A detailed history of Cutter & CO Brokerage, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 11,762 shares of VRTX stock, worth $5.65 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

11,762

Previous 11,542 1.91%

Holding current value

$5.65 Million

Previous $5.37 Million 11.76%

% of portfolio

1.26%

Previous 1.32%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$396.64 - $516.74 $87,260 - $113,682	220 Added 1.91%	11,762 $4.74 Million
Q3 2024 Oct 25, 2024	SELL	$460.0 - $505.78 $88,320 - $97,109	-192 Reduced 1.64%	11,542 $5.37 Million
Q2 2024 Jul 31, 2024	SELL	$392.81 - $485.53 $68,348 - $84,482	-174 Reduced 1.46%	11,734 $5.5 Million
Q1 2024 Apr 30, 2024	BUY	$407.69 - $446.08 $47,292 - $51,745	116 Added 0.98%	11,908 $4.98 Million
Q4 2023 Feb 01, 2024	SELL	$343.0 - $410.68 $71,687 - $85,832	-209 Reduced 1.74%	11,792 $4.8 Million
Q3 2023 Oct 31, 2023	SELL	$338.18 - $362.46 $36,861 - $39,508	-109 Reduced 0.9%	12,001 $4.17 Million
Q2 2023 Aug 01, 2023	BUY	$314.42 - $351.91 $23,581 - $26,393	75 Added 0.62%	12,110 $4.26 Million
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $39,935 - $45,557	-141 Reduced 1.16%	12,035 $3.79 Million
Q4 2022 Feb 03, 2023	SELL	$285.76 - $321.48 $32,005 - $36,005	-112 Reduced 0.91%	12,176 $3.52 Million
Q3 2022 Nov 03, 2022	SELL	$273.83 - $305.53 $12,322 - $13,748	-45 Reduced 0.36%	12,288 $3.56 Million
Q2 2022 Jul 28, 2022	SELL	$234.96 - $292.55 $219,687 - $273,534	-935 Reduced 7.05%	12,333 $3.48 Million
Q1 2022 May 03, 2022	BUY	$221.42 - $260.97 $185,549 - $218,692	838 Added 6.74%	13,268 $3.46 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $54,873 - $69,269	310 Added 2.56%	12,430 $2.73 Million
Q3 2021 Nov 02, 2021	BUY	$181.39 - $202.99 $40,812 - $45,672	225 Added 1.89%	12,120 $2.2 Million
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $196,864 - $232,155	1,050 Added 9.68%	11,895 $2.4 Million
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $1.37 Million - $1.6 Million	6,615 Added 156.38%	10,845 $2.33 Million
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $875,652 - $1.17 Million	4,230 New	4,230 $1 Million

Others Institutions Holding VRTX

# of Institutions

1,754

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $123B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.

Account

Cutter & CO Brokerage, Inc. Vertex Pharmaceuticals Inc Transaction History